BGR Elects Four New Firm Principals

January 25, 2022 – BGR Group, Washington, D.C.’s premier bipartisan lobbying and public relations firm, today announced that Dan Farmer (Health and Life Sciences), Pete Landrum (Financial Services), Joe Lai (Commerce), and Jerry Strickland (State Advocacy and Appropriations) have been elected by their colleagues to be principals in the firm.

“BGR continues to expand and offer our clients top notch analysis and guidance on key policy challenges,” said Erskine Wells, President of BGR Group. “Dan, Pete, Joe and Jerry have been outstanding colleagues and contributors to BGR’s success. Their election as principals reflects their hard work and high level of performance in service of BGR’s clients.”

 

 

Dan Farmer Named Co-Lead of BGR’s Access & Reimbursement Working Group

Washington, D.C. (October 22, 2021) – BGR Group, Washington, D.C.’s premier bipartisan lobbying and public relations firm, has named Health and Life Sciences Practice Vice President Dan Farmer Co-Lead of the Practice’s Access & Reimbursement Working Group. As a veteran of payment policy work in both the public and private sectors, Farmer helps clients better understand the complex rules and administrative actions pertaining to access and reimbursement for medical products and services. He also helps support client relationships with key health care officials in the administration and on Capitol Hill.

“Dan continues to go above and beyond for our clients on a daily basis,” Health and Life Science Practice Co-Head Dr. Remy L. Brim, Ph.D., said. “His expertise and attention to detail make him a standout at BGR and in the health care space. We are proud to have him on the team and as co-lead of this critical working group.”

BGR’s Access & Reimbursement Working Group, which Farmer co-leads with BGR Principal Robb Walton, works with provider groups and medical product manufacturers, as well as other leading companies and trade associations throughout our nation’s health care delivery system. The Access & Reimbursement team works on all policy matters pertaining to the Centers for Medicare and Medicaid Service (CMS) as well as the state and federal commercial insurance marketplace. Additionally, this team works directly with CMS to provide client insights on how to ensure patient access to important treatments and services.

Prior to joining BGR, Farmer coordinated federal affairs at the Cleveland Clinic. He previously served in several roles at the CMS, including a stint in the Center for Medicare and Medicaid Innovation, and in the Center for Medicare, where he focused on Medicare payment policy. He was also a Democratic staffer for a key House Energy and Commerce Committee member during the drafting and passage of the Affordable Care Act.

BGR Group Promotes Dan Farmer to VP for Policy Analysis and Strategy

FOR IMMEDIATE RELEASE

October 8, 2020 – BGR Group, one of Washington’s premier bipartisan lobbying and public relations firms, today promoted Dan Farmer, a former Centers for Medicare & Medicaid Services (CMS) official and Democratic congressional aide, to Vice President for Policy Analysis and Strategy within the Health and Life Sciences Practice.

Prior to joining BGR earlier this year, Farmer coordinated federal affairs at the Cleveland Clinic. He previously served in several roles at the CMS, including a stint in the Center for Medicare and Medicaid Innovation, and in the Center for Medicare, where he focused on Medicare payment policy. He was also a Democratic staffer for a key House Energy and Commerce Committee member during the drafting and passage of the Affordable Care Act.

“Dan has been a tremendous asset to BGR and its clients since he joined us in January,” said Remy Brim, Co-Head of BGR’s Health and Life Sciences Practice. “Dan’s extensive experience navigating the regulatory environment and political processes in Washington has been vital to providing steady guidance and timely analysis during this exceptionally volatile time.”

Farmer’s work focuses on helping clients better understand the complex rules and administrative actions pertaining to access and reimbursement for medical products and services and supporting their relationships with CMS and beyond.